Recon Technology Partners to Enhance Migraine Treatment Access for Federal Healthcare Beneficiaries

Recon Supply Enhances Access to Innovative Migraine Treatment for Federal Healthcare

Recon Supply takes a significant step forward in the realm of medical technology by incorporating eNeura Inc.'s SAVI Dual sTMS Neuromodulation treatment into its Federal Supply Schedule (FSS) contract, effective January 24, 2025. This partnership is poised to broaden the availability of an advanced, FDA-cleared, non-invasive therapy designed for the treatment and prevention of migraines among veterans, active-duty military personnel, and other federal healthcare beneficiaries. The SAVI Dual sTMS treatment utilizes Transcranial Magnetic Stimulation (TMS) technology, distinguished as the first and only portable, patient-controlled TMS device on the market, offering patients a unique method to manage their migraine conditions.

The integration of the SAVI Dual sTMS treatment into the FSS contract signals a crucial development for federal healthcare agencies, such as the Department of Veterans Affairs (VA), Department of Defense (DOD), and Indian Health Services (IHS). These agencies can now procure the innovative therapy at negotiated prices, ensuring that eligible patients can access the treatment more efficiently. Teresa Kazaros, COO of eNeura Inc., underscores the importance of this partnership, highlighting the company's commitment to delivering cutting-edge migraine treatment options to those who serve the nation. By streamlining access to this technology, Recon Supply enhances the overall quality of care available to military personnel and veterans suffering from chronic migraines.

Steve Clark, CEO of Recon Supply, indicates that this collaboration aligns with the company's broader mission to provide innovative medical solutions that improve patient outcomes. With millions of Americans grappling with migraines, including a substantial number of veterans, the addition of SAVI Dual sTMS treatment to the FSS contract represents a pivotal advancement in addressing this debilitating condition. The partnership not only enhances patient care but also fosters a supportive environment for those who have dedicated their lives to serving the country.

In addition to this development, the partnership reflects a growing trend within the medical technology sector to prioritize veteran healthcare. By focusing on non-invasive treatment options, companies like eNeura and Recon Supply are working towards alleviating the burdens faced by veterans living with chronic pain. The collaboration is a testament to the importance of innovative solutions in the healthcare landscape, ensuring that those who have served receive the best possible care.

Overall, the inclusion of the SAVI Dual sTMS treatment in Recon Supply's Federal Supply Schedule marks a notable milestone in advancing migraine treatment accessibility for federal beneficiaries, fostering improved quality of life for countless individuals.